Transaction · 0001140361-26-035375

Venker Eric

Venker Eric, PRES, IC, reported a transaction classified as exercise at Roivant Sciences Ltd. involving 200000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 3844834.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MPRES, IC
ROIVRoivant Sciences Ltd.
Filing timeSep 02
Trade dateAug 28, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$34.52
Pre-filing
1mo ago -4.8%1w ago +5.1%1d ago +8.9%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

ROIV price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ROIV since 2026-09-02Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001140361-26-035375
Stock Option (Right to Buy)
Transaction date
Aug 28, 2026
Filed Sep 02, 2026, 01:00 AM · 5d delay
Shares
200k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
3.84M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership 10b5-1 Detected
-20score
Filing-only score

-20

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President & Immunovant CEO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.17 to $36.16, inclusive. The reporting person undertakes to provi…

  2. F2

    The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.17 to $36.80, inclusive. The reporting person undertakes to provi…

  3. F3

    Reflects an award of stock options to purchase Common Shares that is fully vested.

Original filing · 0001140361-26-035375
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ROIV